Despite antiretroviral therapy (ART), individuals with HIV maintain an HIV reservoir with high levels of systemic inflammation and are more likely to have non-AIDs-defining events compared to those without HIV. We performed a case-control study of AIDS Clinical Trials Group (ACTG) participants to assess the relationship of HIV reservoir size with levels of systemic inflammation, viral co-infections, and risk of non-AIDS-defining events.
Participants were ART-naïve at the time of enrollment, maintained plasma HIV-1 RNA levels <400 copies/mL after ART initiation, and were part of a long-term ACTG follow-up cohort. Cases were defined as participants who had a non-AIDS-related event (MI, stroke, non-AIDS-defining malignancy, serious bacterial infection, or death from a non-AIDS-defining event). Controls were identified and matched based on age, sex, baseline CD4+ T-cell count, and ART regimen. PBMCs and plasma specimens were collected at both 1 year after ART initiation and at the pre-event time point, and analyzed for levels of IL-6, sCD14, interferon γ (IFN-γ), inducible protein 10 (IP10), sTNFR-I, sTNFR-II, D-dimer, CMV and EBV DNA and antibody levels. T-cell phenotyping was performed by flow cytometry. Total HIV DNA levels in PBMCs were measured by qPCR. Adjusted and unadjusted conditional logistic regression analyses were performed to determine if HIV DNA levels predicted the occurrence of non-AIDS-defining events.
Samples from 102 cases and 201 controls at year 1 and from 65 cases and 110 controls pre-event were included. Total HIV DNA levels at either 1 year after ART initiation or pre-event were not predictive of non-AIDS-defining events in either unadjusted models or models adjusted for baseline viral load, immune status, or other co-morbidities. One year after ART initiation, there were modest associations between levels of HIV DNA and CMV IgG (Spearman r=0.20, p=0.01), EBV DNA (r=0.14, p=0.05), IL-6 (r=0.18, p=0.01), D-dimer (r=0.22, p<0.01), sCD14 (r=0.18, p=0.01), and sTNFR-I (r=0.15, p=0.03).
The size of the HIV reservoir, as reflected by the levels of total HIV DNA, was not predictive of non-AIDs-defining events. The associations of HIV reservoir size with EBV/CMV co-infections and inflammatory markers suggest potential interactions between host immune responses and HIV persistence.